Keyphrases
Pristane-induced Lupus
100%
Lupus
100%
Diffuse Alveolar Hemorrhage
80%
Systemic Lupus Erythematosus
80%
Dead Cells
60%
Pristane
40%
Macrophage Subsets
40%
Lung Inflammation
40%
Toll-like
40%
Chronic Inflammation
40%
Inflammation
40%
Systemic Lupus Erythematosus Patient
40%
Phagocytosis
40%
Anti-inflammatory Response
20%
Phagocytic Defects
20%
Phagocytosis of Apoptotic Cells
20%
Immunological Pathways
20%
Hematological Manifestations
20%
Apoptotic Cells
20%
Inflammatory Pathways
20%
Novel Mechanism
20%
Specific Intent
20%
Nephritis
20%
Inflammasome
20%
Macrophages
20%
Signaling Pathway
20%
Autoimmunity
20%
Monocyte-derived Macrophages
20%
Innate Immune Response
20%
Clinical Syndromes
20%
Clinical Features
20%
Arthritis
20%
Tissue Damage
20%
Autoantibody Production
20%
Inflammatory Cytokine Response
20%
Pharmacology, Toxicology and Pharmaceutical Science
Pristane-Induced Lupus
100%
Systemic Lupus Erythematosus
100%
Lung Hemorrhage
66%
Inflammation
50%
Pristane
33%
Cytokine
33%
Chronic Inflammation
33%
Toll Like Receptor 7
33%
Pneumonia
33%
Nephritis
16%
Syndrome
16%
Tissue Injury
16%
Inflammasome
16%
Autoantibodies
16%
Arthritis
16%
Anti-Inflammatory Drug
16%
Clinical Feature
16%
Receptor
16%
Immunology and Microbiology
Pristane-Induced Lupus
100%
Systemic Lupus Erythematosus
100%
Lupus Erythematosus
83%
Phagocytosis
50%
Macrophage Subset
33%
Pulmonary Inflammation
33%
Toll-Like Receptor
33%
Cytokine Production
16%
Innate Immune System
16%
Cytokine
16%
Autoimmunity
16%
Proinflammatory Cytokine
16%
Nephritis
16%
Inflammation Response
16%
Macrophage
16%
Autoantibodies
16%
Arthritis
16%
Inflammasome
16%